Jason V. Coloma, Chief Executive Officer at Maze Therapeutics, Inc. (MAZE), sold 1,938 shares at $26.00 ($50K) on 2026-05-15, disclosed to the SEC on 2026-05-18.
Scheduled sale ($50k) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $26.00 | 116 | $3K | 6.0% |
| 2 | $26.00 | 1,822 | $47K | 94.0% |
| Total | $26.00 avg | 1,938 | $50K | 100% |
| Filing → |
| MAZE | SELL | 2026-08-05 | $922K | — | Filing → |
| MAZE | SELL | 2026-07-02 | $1.0M | — | Filing → |
| MAZE | SELL | 2026-06-24 | $725K | — | Filing → |